Peter Charbel Issa
Peter’s research focusses on phenotyping retinal disease, developing and applying novel imaging technologies, and translating novel therapies into clinical application. He has a strong interest in improving the understanding and management of retinal disease, including macular telangiectasia diseases type 2, pseudoxanthoma elasticum, Stargardt disease and age-related macular degeneration (AMD). Peter is principal investigator for several clinical trials that investigate novel treatments for these diseases.
Peter Charbel Issa is a Consultant Ophthalmic Surgeon specialising in retinal diseases. After his undergraduate training in Jena, Freiburg and London, he received his clinical and research training at the Universities of Würzburg, Bonn and Oxford. He then held a Professorship for Degenerative Retinal Diseases at the University of Bonn, where he was also Coordinator for Ophthalmology in the Centre for Rare Diseases. He returned to Oxford in 2016 where his research is focused on inherited retinal dystrophies including Stargardt disease and retinitis pigmentosa, age-related macular degeneration (AMD), and retinal imaging/phenotyping.
His research work has resulted in numerous awards and distinctions, including the prestigious Marie-Curie-Fellowship, the Research Award of the German Society of Ophthalmology, the Macula Research Award for the prevention of blindness, and a GEROK-Scholarship. He is a member of the scientific advisory board of the ProRetina patient organization, co-organizer for the “ProRetina Research Colloquium”, and elected member of the “Retinal Dystrophies Expert Committee” of the European Vision Institute Clinical Research Network. He is Editorial Board Member of the journals RETINA and Ophthalmic Research.